Hite Christopher
SEC insider (Form 3/4/5 filer). CIK 0001814238. EVP & Chairman, Partnering at Royalty Pharma plc (RPRX) and 2 other issuers. 20 reported Form 4/5 transactions since Sep 2024; latest on Sep 22, 2026. Located in NEW YORK, NY.
Companies Hite Christopher has filed insider reports for
- Royalty Pharma plc (RPRX): Officer, EVP & Chairman, Partnering
- Kailera Therapeutics, Inc. (KLRA): Director
- Vera Therapeutics, Inc. (VERA): Director
Hite Christopher
CIK: 0001814238
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Sep 22, 2026RPRX
Royalty Pharma plc
SaleIndirect3.9K shares at avg. $58.93$231K - Sep 22, 2026RPRX
Royalty Pharma plc
SaleIndirect96.1K shares at avg. $58.51$5.6M - Aug 19, 2026RPRX
Royalty Pharma plc
GiftDirect16.8K shares- - Aug 18, 2026RPRX
Royalty Pharma plc
SaleIndirect100K shares at avg. $59.97$6.0M - Aug 5, 2026RPRX
Royalty Pharma plc
AwardIndirect11K shares- - Jun 30, 2026RPRX
Royalty Pharma plc
SaleIndirect97.4K shares at avg. $56.50$5.5M - Jun 30, 2026RPRX
Royalty Pharma plc
SaleIndirect2.6K shares at avg. $57.10$146K - Jun 30, 2026RPRX
Royalty Pharma plc
SaleDirect29.4K shares at avg. $56.44$1.7M - Jun 30, 2026RPRX
Royalty Pharma plc
SaleDirect600 shares at avg. $57.09$34K - Jun 23, 2026RPRX
Royalty Pharma plc
SaleIndirect32.4K shares at avg. $54.11$1.8M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 22, 2026 |  RPRX Royalty Pharma plc | Sale | 3,927 | $58.93 | $231,403 | Indirect |
| Sep 22, 2026 | RPRX Royalty Pharma plc | Sale | 96,073 | $58.51 | $5,621,692 | Indirect |
| Aug 19, 2026 | RPRX Royalty Pharma plc | Gift | 16,800 | - | $0 | Direct |
| Aug 18, 2026 | RPRX Royalty Pharma plc | Sale | 100,000 | $59.97 | $5,997,250 | Indirect |
| Aug 5, 2026 | RPRX Royalty Pharma plc | Award | 11,002 | - | $0 | Indirect |
| Jun 30, 2026 | RPRX Royalty Pharma plc | Sale | 97,446 | $56.50 | $5,505,972 | Indirect |
| Jun 30, 2026 | RPRX Royalty Pharma plc | Sale | 2,554 | $57.10 | $145,841 | Indirect |
| Jun 30, 2026 | RPRX Royalty Pharma plc | Sale | 29,400 | $56.44 | $1,659,404 | Direct |
| Jun 30, 2026 | RPRX Royalty Pharma plc | Sale | 600 | $57.09 | $34,254 | Direct |
| Jun 23, 2026 | RPRX Royalty Pharma plc | Sale | 32,408 | $54.11 | $1,753,500 | Indirect |
1-10 of 20 transactions